Thu. 2 May 2024, 4:19pm ET
Benzinga
Earnings, Earnings Misses, News
Kura Oncology (NASDAQ:KURA) reported quarterly losses of $(0.59) per share which missed the analyst consensus estimate of $(0.55) by 7.27 percent. This is a 18 percent decrease over losses of $(0.50) per share from the same period last year.